PL354322A1 - 2'-podstawione 1,1'-bifenylo-2-karbonamidy, sposób ich wytwarzania, ich zastosowanie jako leku i zawierające je preparaty farmaceutyczne - Google Patents

2'-podstawione 1,1'-bifenylo-2-karbonamidy, sposób ich wytwarzania, ich zastosowanie jako leku i zawierające je preparaty farmaceutyczne

Info

Publication number: PL354322A1
Authority: PL; Poland
Prior art keywords: carbonamides; biphenyl; medicament; substituted; compounds
Prior art date: 1999-10-02

Application number

PL00354322A

Other languages

English (en)

Other versions

PL204034B1 (pl

Inventor

Joachim Brendel

Wolfgang Schmidt

Peter Below

Original Assignee

Aventis Pharma Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-02

Filing date

2000-09-19

Publication date

2004-01-12

2000-09-19 Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh

2004-01-12 Publication of PL354322A1 publication Critical patent/PL354322A1/pl

2009-12-31 Publication of PL204034B1 publication Critical patent/PL204034B1/pl

Links

150000001875 compounds Chemical class 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/54—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/47—Y being a hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Furan Compounds (AREA)

PL354322A 1999-10-02 2000-09-19 2'-podstawione 1,1'-bifenylo-2-karbonamidy, ich zastosowanie jako leku, zawierające je preparaty farmaceutyczne oraz ich zastosowanie do wytwarzania leków PL204034B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19947457A DE19947457A1 (de)	1999-10-02	1999-10-02	2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
PCT/EP2000/009151 WO2001025189A1 (de)	1999-10-02	2000-09-19	2'-substituierte 1,1'-biphenyl-2-carbonamide, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltende pharmazeutische zubereitungen

Publications (2)

Publication Number	Publication Date
PL354322A1 true PL354322A1 (pl)	2004-01-12
PL204034B1 PL204034B1 (pl)	2009-12-31

Family

ID=7924254

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL354322A PL204034B1 (pl)	1999-10-02	2000-09-19	2'-podstawione 1,1'-bifenylo-2-karbonamidy, ich zastosowanie jako leku, zawierające je preparaty farmaceutyczne oraz ich zastosowanie do wytwarzania leków

Country Status (32)

Country	Link
EP (1)	EP1222163B1 (pl)
JP (1)	JP4713800B2 (pl)
KR (1)	KR100722178B1 (pl)
CN (1)	CN1195738C (pl)
AR (1)	AR031226A1 (pl)
AT (1)	ATE332890T1 (pl)
AU (1)	AU766365B2 (pl)
BR (1)	BR0014465B1 (pl)
CA (1)	CA2385859C (pl)
CY (1)	CY1106178T1 (pl)
CZ (1)	CZ302591B6 (pl)
DE (2)	DE19947457A1 (pl)
DK (1)	DK1222163T3 (pl)
EE (1)	EE05000B1 (pl)
ES (1)	ES2265985T3 (pl)
HK (1)	HK1048986B (pl)
HR (1)	HRP20020264B1 (pl)
HU (1)	HU229046B1 (pl)
IL (2)	IL148870A0 (pl)
ME (1)	MEP60908A (pl)
MX (1)	MXPA02002691A (pl)
NO (1)	NO327709B1 (pl)
NZ (1)	NZ518065A (pl)
PL (1)	PL204034B1 (pl)
PT (1)	PT1222163E (pl)
RS (1)	RS50387B (pl)
RU (1)	RU2252214C2 (pl)
SK (1)	SK286756B6 (pl)
TR (1)	TR200200883T2 (pl)
TW (1)	TWI270541B (pl)
WO (1)	WO2001025189A1 (pl)
ZA (1)	ZA200202521B (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7091247B2 (en)	2000-06-28	2006-08-15	Takeda Pharmaceutical Company Limited	Biphenyl compound
DE10059418A1 (de) *	2000-11-30	2002-06-20	Aventis Pharma Gmbh	Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10060807A1 (de) *	2000-12-07	2002-06-20	Aventis Pharma Gmbh	Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
TWI311133B (en)	2001-04-20	2009-06-21	Eisai R&D Man Co Ltd	Carboxylic acid derivativeand the salt thereof
DE10121003A1 (de)	2001-04-28	2002-12-19	Aventis Pharma Gmbh	Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
EP1394147A4 (en) *	2001-06-04	2007-10-24	Eisai R&D Man Co Ltd	CARBOXYLENE DERIVATIVE AND A SALT OR AN ESTER CONTAINING MEDICINE
DE10128331A1 (de) *	2001-06-12	2002-12-19	Aventis Pharma Gmbh	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
AU2002367427A1 (en) *	2001-12-28	2003-07-24	Takeda Chemical Industries, Ltd.	Biaryl compound and use thereof
EP1562905A2 (en) *	2002-10-24	2005-08-17	MERCK PATENT GmbH	Methylene urea derivatives as raf-kinase inhibitors
DE10312061A1 (de) *	2003-03-18	2004-09-30	Aventis Pharma Deutschland Gmbh	Kombination von Phenylcarbonsäureamiden mit Blockern des IK-Kanals und deren Verwendung zur Behandlung von Vorhofarrhythmien
GB0315950D0 (en)	2003-06-11	2003-08-13	Xention Discovery Ltd	Compounds
CA2536954C (en) *	2003-08-29	2012-11-27	Exelixis, Inc.	C-kit modulators and methods of use
DE10341233A1 (de) *	2003-09-08	2005-03-24	Aventis Pharma Deutschland Gmbh	Kombination von Phenylcarbonsäureamiden mit beta-Adrenozeptoren-Blockern und deren Verwendung zur Behandlung von Vorhofarrhythmien
DE102004009931A1 (de) *	2004-02-26	2005-09-15	Aventis Pharma Deutschland Gmbh	Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz
US20090253908A1 (en) *	2004-03-11	2009-10-08	Glaxo Group Limited	Novel m3 muscarinic acetylchoine receptor antagonists
GB0412986D0 (en)	2004-06-10	2004-07-14	Xention Discovery Ltd	Compounds
US7569589B2 (en)	2004-07-29	2009-08-04	Merck & Co., Inc.	Potassium channel inhibitors
US7576212B2 (en)	2004-12-09	2009-08-18	Xention Limited	Thieno[2,3-B] pyridines as potassium channel inhibitors
GB0525164D0 (en)	2005-12-09	2006-01-18	Xention Discovery Ltd	Compounds
KR101390239B1 (ko) *	2006-04-27	2014-04-30	사노피-아벤티스 도이칠란트 게엠베하	Ｔａｓｋ-1 및 ｔａｓｋ-3 이온 채널 억제제
GB0815782D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815781D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815784D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
BRPI1011098A2 (pt) *	2009-06-03	2016-04-12	Sanofi Aventis Deutschland	fases cristalinas de (2-piridin-3-il-etil)-amida de ácido 2'-{[2-(4-metóxi-fenil)-acetilamino]metil}-bifenil-2-carboxílico.
GB201105659D0 (en)	2011-04-01	2011-05-18	Xention Ltd	Compounds
NO3175985T3 (pl)	2011-07-01	2018-04-28
WO2013112932A1 (en)	2012-01-27	2013-08-01	Gilead Sciences, Inc.	Combination therapies using late sodium ion channel blockers and potassium ion channel blockers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8705150D0 (sv) *	1987-12-23	1987-12-23	Haessle Ab	Novel antiarrhythmic agents
DE4102024A1 (de) *	1991-01-24	1992-07-30	Thomae Gmbh Dr K	Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9307527D0 (en) *	1993-04-13	1993-06-02	Fujisawa Pharmaceutical Co	New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

1999
- 1999-10-02 DE DE19947457A patent/DE19947457A1/de not_active Withdrawn
2000
- 2000-01-11 TW TW2'-SUBSTIA patent/TWI270541B/zh not_active IP Right Cessation
- 2000-09-19 RS YUP-244/02A patent/RS50387B/sr unknown
- 2000-09-19 HU HU0203505A patent/HU229046B1/hu not_active IP Right Cessation
- 2000-09-19 NZ NZ518065A patent/NZ518065A/en not_active IP Right Cessation
- 2000-09-19 DK DK00967703T patent/DK1222163T3/da active
- 2000-09-19 RU RU2002111561/04A patent/RU2252214C2/ru not_active IP Right Cessation
- 2000-09-19 WO PCT/EP2000/009151 patent/WO2001025189A1/de not_active Ceased
- 2000-09-19 AU AU77778/00A patent/AU766365B2/en not_active Ceased
- 2000-09-19 CA CA002385859A patent/CA2385859C/en not_active Expired - Fee Related
- 2000-09-19 HR HR20020264A patent/HRP20020264B1/xx not_active IP Right Cessation
- 2000-09-19 ME MEP-609/08A patent/MEP60908A/xx unknown
- 2000-09-19 IL IL14887000A patent/IL148870A0/xx active IP Right Grant
- 2000-09-19 PT PT00967703T patent/PT1222163E/pt unknown
- 2000-09-19 DE DE50013167T patent/DE50013167D1/de not_active Expired - Lifetime
- 2000-09-19 ES ES00967703T patent/ES2265985T3/es not_active Expired - Lifetime
- 2000-09-19 MX MXPA02002691A patent/MXPA02002691A/es active IP Right Grant
- 2000-09-19 JP JP2001528137A patent/JP4713800B2/ja not_active Expired - Fee Related
- 2000-09-19 EE EEP200200160A patent/EE05000B1/xx not_active IP Right Cessation
- 2000-09-19 EP EP00967703A patent/EP1222163B1/de not_active Expired - Lifetime
- 2000-09-19 HK HK03101193.0A patent/HK1048986B/zh not_active IP Right Cessation
- 2000-09-19 BR BRPI0014465-7A patent/BR0014465B1/pt not_active IP Right Cessation
- 2000-09-19 CN CNB008127344A patent/CN1195738C/zh not_active Expired - Fee Related
- 2000-09-19 TR TR2002/00883T patent/TR200200883T2/xx unknown
- 2000-09-19 PL PL354322A patent/PL204034B1/pl unknown
- 2000-09-19 KR KR1020027004267A patent/KR100722178B1/ko not_active Expired - Fee Related
- 2000-09-19 AT AT00967703T patent/ATE332890T1/de active
- 2000-09-19 SK SK438-2002A patent/SK286756B6/sk not_active IP Right Cessation
- 2000-09-19 CZ CZ20021144A patent/CZ302591B6/cs not_active IP Right Cessation
- 2000-09-28 AR ARP000105117A patent/AR031226A1/es active IP Right Grant
2002
- 2002-03-20 NO NO20021398A patent/NO327709B1/no not_active IP Right Cessation
- 2002-03-25 IL IL148870A patent/IL148870A/en not_active IP Right Cessation
- 2002-03-28 ZA ZA200202521A patent/ZA200202521B/xx unknown
2006
- 2006-09-28 CY CY20061101413T patent/CY1106178T1/el unknown

Also Published As

Publication number	Publication date
HUP0203505A3 (en)	2004-01-28
HRP20020264A2 (en)	2004-02-29
HRP20020264B1 (hr)	2010-08-31
JP2003511363A (ja)	2003-03-25
PL204034B1 (pl)	2009-12-31
HK1048986B (zh)	2005-07-29
SK4382002A3 (en)	2002-08-06
HU229046B1 (hu)	2013-07-29
BR0014465A (pt)	2002-06-11
TR200200883T2 (tr)	2002-09-23
NO327709B1 (no)	2009-09-14
WO2001025189A1 (de)	2001-04-12
IL148870A (en)	2007-05-15
ES2265985T3 (es)	2007-03-01
MEP60908A (en)	2011-05-10
KR20020038791A (ko)	2002-05-23
NO20021398L (no)	2002-05-31
RS50387B (sr)	2009-12-31
CZ20021144A3 (cs)	2002-06-12
NZ518065A (en)	2004-08-27
EE200200160A (et)	2003-04-15
RU2252214C2 (ru)	2005-05-20
DK1222163T3 (da)	2006-11-13
IL148870A0 (en)	2002-09-12
JP4713800B2 (ja)	2011-06-29
CN1373750A (zh)	2002-10-09
DE50013167D1 (de)	2006-08-24
EE05000B1 (et)	2008-04-15
AU766365B2 (en)	2003-10-16
ATE332890T1 (de)	2006-08-15
TWI270541B (pl)	2007-01-11
BR0014465B1 (pt)	2011-12-27
KR100722178B1 (ko)	2007-05-29
PT1222163E (pt)	2006-10-31
CY1106178T1 (el)	2011-06-08
NO20021398D0 (no)	2002-03-20
DE19947457A1 (de)	2001-04-05
AR031226A1 (es)	2003-09-17
HK1048986A1 (en)	2003-04-25
ZA200202521B (en)	2002-12-24
CA2385859A1 (en)	2001-04-12
YU24402A (sh)	2005-06-10
CZ302591B6 (cs)	2011-07-27
SK286756B6 (sk)	2009-05-07
CA2385859C (en)	2009-11-24
EP1222163B1 (de)	2006-07-12
RU2002111561A (ru)	2004-01-20
CN1195738C (zh)	2005-04-06
HUP0203505A2 (hu)	2003-03-28
MXPA02002691A (es)	2002-07-30
EP1222163A1 (de)	2002-07-17
AU7777800A (en)	2001-05-10

Publication	Publication Date	Title
PL354322A1 (pl)	2004-01-12	2'-podstawione 1,1'-bifenylo-2-karbonamidy, sposób ich wytwarzania, ich zastosowanie jako leku i zawierające je preparaty farmaceutyczne
PL345863A1 (en)	2002-01-14	Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
IL147220A0 (en)	2002-08-14	Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
HUP0303317A3 (en)	2010-04-28	Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
HUP0400932A3 (en)	2007-11-28	Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same
HUP0203766A3 (en)	2008-01-28	5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HUP0203542A3 (en)	2003-07-28	3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
IL135920A0 (en)	2001-05-20	2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP0001508A3 (en)	2003-01-28	4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP0002843A3 (en)	2001-07-30	New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
AU3162001A (en)	2001-07-03	Medicament, a method for its production and the use thereof
HUP0104033A3 (en)	2002-08-28	1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
HUP0204360A3 (en)	2005-04-28	Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament and medicaments containing said compounds
HRP950363A2 (en)	1997-08-31	Novel chemical compound, its preparation and use as a drug
ZA988711B (en)	2000-03-23	New tetracycles, process for their production and pharmaceutical preparations containing these compounds.
HUP0200376A3 (en)	2003-07-28	Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
IL145041A0 (en)	2002-06-30	Novel morpholine derivatives, methods for the production thereof and pharmaceutical preparations containing said derivatives
ZA9810403B (en)	2000-05-15	New epothilon derivatives, process for their preparation and their pharmaceutical use.
IL142848A0 (en)	2002-03-10	Vancoresmycin, a process for its production and its use as a pharmaceutical
IL128238A0 (en)	1999-11-30	11-Acetyl-12, 13-dioxabicyclo [8.2.1]-tridecenone derivatives processes for the preparation thereof and medicaments containing these compounds
HUP0102370A3 (en)	2003-10-28	Mumbaistatin, a process for its production and its use as a pharmaceutical
SI1222163T1 (sl)	2006-10-31	2'-substituirani 1,1'-bifenil-2-karboksamidi, postopek za njihovo pripravo, njihova uporaba kot zdravilo, kot tudi farmacevtski pripravki, ki jih vsebujejo
AU4463797A (en)	1998-04-17	New heteroaryloxyethylamines, a process for the preparation thereof, their use as medicaments, and pharmaceutical compositions containing them
SI1098874T1 (en)	2004-02-29	Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
AU1996200A (en)	2000-07-31	Phthalazine derivatives, a process for the preparation thereof, and a pharmaceutical composition containing the same